Astellas Pharma's dividends per share for the
three
months ended in Mar. 2026 was $0.25. Its dividends per share for the trailing twelve months (TTM) ended in Mar. 2026 was $0.51. Its Dividend Payout Ratio for the
three
months ended in Mar. 2026 was 1.63. As of today, Astellas Pharma's Dividend Yield % is 3.49%.
During the past 12 months, Astellas Pharma's average Dividends Per Share Growth Rate was 5.40% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was 9.10% per year.
During the past 5 years, the average Dividends Per Share Growth Rate was 13.50% per year.
During the past 10 years, the average Dividends Per Share Growth Rate was 10.20% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Astellas Pharma was 52.50% per year. The lowest was 1.30% per year. And the median was 7.60% per year.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
Astellas Pharma (OTCPK:ALPMF) Dividends per Share Explanation
1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.
Astellas Pharma's Dividend Payout Ratio for the quarter that ended in Mar. 2026 is calculated as
During the past 13 years, the highest Dividend Payout Ratio of Astellas Pharma was 12.12. The lowest was 0.33. And the median was 0.57.
2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.
Astellas Pharma Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
JPY 39.000000
2026-03-30
2026-03-31
2026-06-03
Cash Dividend
semi-annually
JPY:USD 0.006286
JPY 39.000000
2025-09-29
2025-09-30
2025-12-01
Cash Dividend
semi-annually
JPY:USD 0.006758
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
Astellas Pharma's Dividend Yield (%) for Today is calculated as
Current Share Price is $14.15.
Astellas Pharma's Dividends per Share for the trailing twelve months (TTM) ended in Today is $0.508716.
During the past 13 years, the highest Dividend Yield of Astellas Pharma was 5.83%. The lowest was 1.82%. And the median was 2.49%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Astellas Pharma Dividends per Share Related Terms
Astellas Pharma Dividends per Share Historical Data
* Premium members only.
The historical data trend for Astellas Pharma's Dividends per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ALPMF vs LLY, JNJ, ABBV: Dividends per Share Comparison
For the Drug Manufacturers - General subindustry, Astellas Pharma's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Astellas Pharma Dividend Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Astellas Pharma's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Astellas Pharma's Dividend Yield % falls into.
Astellas Pharma (ALPMF) has a Dividends per Share of $0.51 as of Mar. 2026. Dividends per share represents the per-share amount paid as dividends. View historical data on Astellas Pharma and its competitors.
Is Astellas Pharma's Dividends per Share too high?
Astellas Pharma's current Dividends per Share is $0.51. Overall, Astellas Pharma has a GF Score™ of 73/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Astellas Pharma's Dividends per Share compare to LLY and JNJ?
Astellas Pharma's Dividends per Share of $0.51 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividends per Share for a Drug Manufacturers company?
A good Dividends per Share depends on the Drug Manufacturers industry context. However, Dividends per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividends per Share mean?
A high Dividends per Share can signal that a stock is expensive relative to its fundamentals. Dividends per share represents the per-share amount paid as dividends. View historical data on Astellas Pharma and its competitors. Astellas Pharma's current Dividends per Share is $0.51. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Astellas Pharma stock overvalued right now?
Based on GuruFocus' analysis, Astellas Pharma (ALPMF) is currently considered Fairly Valued. The stock's GF Value™ is $14.60, compared to a current price of $14.15 — trading 3.1% below its estimated fair value. The current Dividends per Share is $0.51. Astellas Pharma's overall GF Score™ is 73/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividends per Share calculated?
Dividends per Share is calculated from a company's financial statements. For Astellas Pharma (ALPMF), the current Dividends per Share is $0.51 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Astellas Pharma (ALPMF) Overvalued in 2026?
Based on GuruFocus' analysis, Astellas Pharma stock appears to be undervalued.
The current stock price of $14.15 is trading 3.1% below its estimated GF Value™ of $14.60.
GuruFocus considers Astellas Pharma to be Fairly Valued.
Key valuation signals for ALPMF:
Dividends per Share: $0.51
GF Value™: $14.60 vs. price of $14.15 (3.1% below fair value)
No single metric tells the full story. See the ALPMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Astellas Pharma Inc is a specialty international pharmaceutical company. The company focuses on accelerating the discovery, development, and commercialization of ground-breaking innovations that could redefine expectations of care for difficult-to-treat diseases. The group is committed to driving innovation in immuno-oncology, gene therapy, mitochondria, blindness and regeneration, and targeted protein degradation. Its core products include anticancer agents like XTANDI, XOSPATA, and PADCEV; VEOZAH for the treatment of vasomotor symptoms due to menopause; Betanis / Myrbetriq / BETMIGA for the treatment of overactive bladder (OAB); and Prograf, an immunosuppressant for organ transplantation.
73GF Score
Get the complete analysis for ALPMF
Dividends per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ALPMF has been successfully added to your 
